Area of research
Nuclear and High Energy Physics · Hematology
Research interest
Research interests include Quantum Chromodynamics and Particle Interactions, Particle physics theoretical and experimental studies, Acute Myeloid Leukemia Research, and High-Energy Particle Collisions Research.
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in <i>RUNX1</i>, <i>GATA2</i>, and <i>DDX41</i>
Clonal hematopoiesis in patients with <i>ANKRD26</i> or <i>ETV6</i> germline mutations
Somatic Mutational Landscape of Hereditary Hematopoietic Malignancies Associated with Germline Variants in <i>RUNX1</i>, <i>GATA2</i> and <i>DDX41</i>
The RUNX1 database (RUNX1db): establishment of an expert curated RUNX1 registry and genomics database as a public resource for familial platelet disorder with myeloid malignancy
Targeted gene panels identify a high frequency of pathogenic germline variants in patients diagnosed with a hematological malignancy and at least one other independent cancer
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma
Comprehensive Analysis of Tumour Sub-Volumes for Radiomic Risk Modelling in Locally Advanced HNSCC
Definition and validation of a radiomics signature for loco-regional tumour control in patients with locally advanced head and neck squamous cell carcinoma
Comparison of subjective evaluation versus objective algorithm in the interpretation of follow-up FDG-PET/CT scans after radiochemotherapy in head and neck cancer patients
Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease
CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer
OC-0508: Identification of tumour sub-volumes for improved radiomic risk modelling in locally advanced HNSCC
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
FDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapy
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck
Expanded Phenotypic and Genetic Heterogeneity in the Clinical Spectrum of FPD-AML: Lymphoid Malignancies and Skin Disorders Are Common Features in Carriers of Germline RUNX1 Mutations
Standard or split TPF induction chemotherapy followed by bioradiation: ICRAT randomized phase II study.
Phase II-trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell head and neck cancer: 5-year end results
Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies
Comparison of Standard to Split-Dose TPF Induction Chemotherapy followed by Bio-radiation for LASCC of the Head and Neck: Results of the ICRAT randomized Phase II Study.
Magnetic catalysis (and inverse catalysis) at finite temperature in two-color lattice QCD
Phase II trial of concomitant hyperfractionated-accelerated radiotherapy (HART) with cisplatin (Cis) plus cetuximab (Cet) for locoregionally advanced inoperable squamous cell carcinoma of the head and neck (LA SCCHN): Feasibility and 2-year OS.
Two-color QCD with staggered fermions at finite temperature under the influence of a magnetic field